Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ochse
Andreas Ochse, Oberkochen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100284652 | COMPOSITE BODY - A composite body is joined together of at least two bodies ( | 11-11-2010 |
Michael Ochse, Wiesbaden DE
| Patent application number | Description | Published |
|---|---|---|
| 20110009378 | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy - The present invention relates to heterocyclic compounds of the formula (I) | 01-13-2011 |
| 20110105502 | TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY - The present invention relates to tetrahydroisoquinoline of the formula (I) | 05-05-2011 |
Michael Ochse, Ludwigshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100222346 | 4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY - The present invention relates to 4-benzylaminoquinolines of the formula (I) or physiologically tolerated salts thereof. The invention relates to pharmaceutical compositions comprising such quinolines, and the use of such quinolines for therapeutic purposes. The quinolines are GIyTI inhibitors. | 09-02-2010 |
Michael Ochse, Bad Durkheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20100041698 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS - The invention relates to compounds of general formula (I), corresponding enantiomeric, diastereomeric and/or tautomeric forms thereof as well as pharmaceutically acceptable salts thereof and the prodrugs of said compounds. The invention also relates to the use of said compounds as binding partners for 5-HT5 receptors for treating diseases that are modulated by a 5-HT5 receptor activity, in particular, for treating neurodegenerative and neuropsychiatric disorders as well as signs, symptoms and dysfunctions. | 02-18-2010 |
| 20100184787 | Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors - The invention relates to the hetaryl-substituted guanidine compounds of general formula (I), enantiomeres, diastereomeres and/or tautomeres thereof, in addition to the pharmaceutically acceptable salts thereof and the prodrugs of the known compounds. The invention also relates to the use of said hetaryl-substituted guanidine compounds as binding partners for 5-HT5-receptors for treating and/or for the prophylaxis of illnesses which are modulated by a 5-HT5-receptor activity, in particular, for treating and/or for the prophylaxis of neurodegenerative and neuropsychiatric disorders, and signs, symptoms and dysfunctions associated with said disorders. | 07-22-2010 |
Michael Ochse, Weisenheim Am Barg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110207788 | 5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors - The invention relates to 5-ring heteroaromatic compounds of general formula (I), their use for the treatment and/or prevention of diseases, and medicaments containing same. | 08-25-2011 |
Micheal Ochse, Ludwigshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100273739 | Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy - The present invention relates to aminotetraline derivatives of the formula (I) | 10-28-2010 |